3 Questions to Ask Yourself When Selecting Quality Medical Supplies

Quality medical supplies are found at the heart of every medical operation you can think of, from big hospitals all the way down to small community clinics. When looked at in another way, you could easily say that these will be the biggest expense that any medical operation has, short of personnel.

Just because it's the biggest expensive doesn't mean that there aren't ways to lower your expenses, or ways to focus on getting the best medical supplies possible. If you've been tasked to handle the ordering of medical supplies, there are just three questions that you will need to ask yourself while you go to select quality medical products.

Naturally, this guide assumes that you will be ordering your medical supplies through the Internet, as going online is the best way to get the deepest discounts and the widest selection. While it's true that there are other sources available, like going into town, the last thing that any busy medical professional should have to do is fight traffic!

Going back to the actual questions, the first thing you should ask yourself is what manufacturer you really want to go with. After all, the last thing that you want to do is select a manufacturer that will not serve your needs well. It's better to pick one or two manufacturers that consistently produce great products than just settle for the one that does a halfway job on the products that they do offer. Your organization's patients deserve the best of care, and that does start with quality medical equipment.

From there, you will need to ask yourself how much you are trying to order at one time. The biggest mistake that many people make at this stage is that they assume they will save the most money by ordering small packages at once, but that's not the case at all. It's better to wait until you have the funds for a very large order, since you will qualify for bulk pricing. It's better to go with bulk pricing since it offers the deepest discounts, which will in turn make it easier for you to order even more equipment as you need it. Some items will not be ordered as frequently, and that's okay -- that will be offset by the everyday run of the mill items that seem to always need ordering.

The final question that you need to ask yourself when selecting quality medical products is how often you want to order them to begin with. Indeed, your initial purchase order is just that -- the beginning of a long line of purchases. By developing a schedule from the beginning, you will be able to eliminate a lot of the hassle and worry of running out of supplies and other stresses that can come about as a result of bad planning.

Overall, these are just guiding questions to get you started -- if you take the tips here to heart, you will have no problem getting quality medical supplies that make the grade each and every time!

Great medical supplies are only a click away -- order yours today!

What Mouli Cohen Has to Say About Biotech Drugs and Innovation

The FTC (Federal Trade Commission), in a recent report, proposed that the 12-14 years that are currently being allotted as a period exclusively for the innovation of products in biotech companies is much longer than required for the purpose.

The report also showed that the development of the generic biotech drugs could be a boon to the health care cost in the U.S. These drugs cost about 10-30%lesser than the conventional drugs in the market today.

The U.S. President, Obama, after the publication of the report, included in his talk to the AMA, the American Medical Association, that the introduction of generic biotech drugs could save the country enormous money. But no one knows how much that money will be and how fast it will be earned.

It is definite that the introduction of generic biotech drugs will be a boon to the economy but this boon is not quantifiable. Also, the biotech sector will undergo some changes that will be immeasurable according to the industry insiders.

According to Mouli Cohen, investor, entrepreneur, philanthropist and the founder of the Voltage Capital is of the view that this proposal shall make innovation less attractive. He believes that innovation and the capability of driving processes towards outcome that are quantifiable is what business is all about. And killing this process can reduce them to just mediocre players. He says that innovation is needed to run a business and there is no alternative to that.

PharmaTiles also pointed out the concerns that if generic biotech drugs come hastily into the market, then will biotech companies recoup their R&D investments?

Cohen states that R&D is very expensive and most of the pharmaceutical companies do not bother investing in R&D. The burden is then transferred to the academia and the biotech companies. AT the end of it, someone has to do the sponsoring. The costs will keep shifting but if any compensation is made and that turns out to be unfavorable, then the entire medical industry will suffer largely. This implies that the biotech sector will suffer some major problems in funding for R&D in the coming five years.

About two thirds of the funds go to the small biotech companies that earn no profits and which heavily rely on private investment.

If the proposal is implanted, then the impact of innovation will be greatly minimized. With these new regulations, the industry is going be subjected to rapid change though the new ideas and the products shall still be as solid as they were. Cohen suggests that care should be taken and consequences should be weighed before any action is taken.

Mike Casnet has been writing articles for 3 years. He like to write business, travel and health articles for different people. He is now developing his own webpage for clients who wants to try his service like Mouli Cohen

Save Money on Your Prescriptions With a Simple, Little Know Pharmaceutical Trick!

For the sake of a case study let's consider you are currently taking Lipitor at a 10 mg per day dosage.

If you purchase Lipitor from Walmart, it will cost you apx. $100.00 per month x 12 months = $1200.00 per year.

Now let's take a look at the cost of that same medication, Lipitor, by simply splitting the pill dosage in half.

Purchase the same pill in 20 mg for Walmart at a cost of $143.00 for 30 tabs x 6 months=$858.00

Now you will only have to purchase the 20 mg. tabs every other month because you will be splitting the dosage in half. Your savings per year would be 342.00 per year.

Same medication, same dosage but greater savings.

Now lets' say you do a little price shopping on Medical Price Point's comparison site.

Right now the cheapest Lipitor we could find is at Target. The cost from their Pharmacy is $98.00 for 30 tabs of 20 mg Lipitor. Multiple that times the 6 months = $564.00 Compared to the 10mg price of $1200.00 per year, you would save a grand total of $636.00

Not bad for just educating yourself on a little known Pharmaceutical trick. You need to remember however, that time released capsules are not splittable and this method will only work with "pills".

Here are a couple more examples;

Sertaline (generic Zoloft) 50 mg pills at Costco x 12 months= $35 x 12= $420/year

Sertraline (generic Zoloft) 100 mg pill at Kmart x 6 months= $5 x 6= $30/year

$420- $30= $390 per year savings

Amlodipine (generic Norvasc) 5 mg pills at Walmart x 12 months= $40 x 12= $480/year

Amlodipine (generic Norvasc) 10 mg pills at Kmart x 6 months= $5 x 6= $30/year

$480 - $30= $450/per year savings

Please take a few minutes and join the community at Medical Price Point, it's Free. Telling others about your medical savings tricks or reading about others will help us build a community of Smarter Medical Shoppers.

Charles Bagley started Medical Price Point for the specific purpose of educating the public on Medical Pricing in the United States. We have compiled pricing from every Medical Field to be used for Free to help the greater public, "nudge" Health Care providers into making pricing more transparent. MedicalPricePoint.com offers a free online community forum to help build a pricing database for all to see and use. Join Medical Price Point's growing community of Member involvement. Get involved, Get educated, Save money!

http://medicalpricepoint.com

Growing Fame of Pharmaceutical Engineering in Various Sectors

Pharmaceutical engineering is a branch of chemical engineering that has a wide range of applications in numerous sectors. It has contributed a lot to medical science by developing medicines for many fatal diseases. These medicines have the potential to fight the deadliest and life-taking diseases. It is a combination of biology, chemistry, physics and biochemistry. It uses the concepts of all these branches to develop effective medicines.

Pharmaceutical engineers have huge job opportunities where they can show their proficiency. Various drug designing centers, pharmaceutical industries, biomedical industries, R&D labs and other sectors are inviting young and dynamic talents to join them and become a pat of their organization. They can practically implement the subjects they have studied under their course. Because of newly emergence of Pharmaceutical Engineering and large requirements of working personnel in biomedical industry and other sectors, graduates are taken into contemplation.

Pharmaceutical engineers must be updated with latest ideas and techniques as they have to develop remedies for those diseases whose solutions are not present till now. They have o discover future medicines also. Their skills and knowledge in numerous subjects can provide them job opportunities in various sectors like nanotechnology, cosmetic, biomedical, nutrition and other work fields. All these are some of the emerging technologies that determine the scope of pharmaceutical engineering. Professionals are highly demanded in numerous fields where they can prove their worth. Hence we can say this branch of science has created wonders in various sectors. The future of this stream is very bright and its success is never ending.

For more information on Pharmaceutical engineering and the benefits of Pharmaceutical engineering please visit the mentioned website

Community-Associated Bacterial Infections on the Rise

For years, health researchers have warned the public of the growing danger of antibiotic-resistant strains of bacteria whose growth is spurred on by the overuse of antibiotic drugs. Doctors often supply antibiotic medication to patients who mistakenly believe that the drugs will help them with a given illness which, in fact, is not treatable with antibiotics (such as viral infections). Some studies indicate that doctors may over-prescribe to avoid conflicts with patients who expect antibiotic treatment for respiratory tract infections (often associated with the common cold virus), despite the fact that only 1 in 4 of those patients actually desires such a treatment.

As the superbug MRSA (short for methicillin-resistant Staphylococcus aureus), a colonizing bacterium which is highly resistant to antibiotics, makes its way into more and more hospitals and other community facilities, the concern over a possible public health epidemic is growing. Between 1999 and 2006, a sevenfold increase in MRSA-related infections was found in outpatient hospital wards.

Today, additional studies indicate that not only are mortality rates and lengths of hospital stays not getting any better, but hospital-associated infections are actually on the rise, accounting for about half of all infection deaths among hospital patients. Previous research has established a link between the two, but the latest reports from scientists studying the phenomenon provide conclusive evidence that community-associated strains are actually the root of many of the infections. The Center for Disease Control reports that about 1.7 million hospital infections occur each year, with 99,000 associated fatalities.

Sepsis, pneumonia, and other infections resulting from exposure to community-associated bacteria could all be reduced by implementing additional measures of safety in hospital wards to reduce the spread of the illnesses, but funding for those measures can be difficult for doctors to justify to administrators. As one doctor notes, "Even when physicians are gung-ho to do something about infection control, they may not have buy-in from hospital administrators. They may still ask, 'Why do you need $500,000 if it isn't going to do anything for the bottom line?'"

The government is beginning to crack down on hospital-related infections by denying payment from Medicaid or Medicare for costs resulting from avoidable complications. Unfortunately, that may not do much good - documentation of such infections isn't easy to track, making the rule harder to enforce. Worse, hospitals could simply avoid such penalties by intentionally misclassifying infections to prevent government programs from denying payout.

In the meantime, the best rule of thumb for antibiotic use is still to try not to use them. If you visit a doctor about an illness, listen carefully to what he or she has to say about the likely cause of your illness. Often a simple blood test can determine if the condition is caused by a virus or a microbe - and remember that antibiotics won't help fight off a virus one bit. If you are prescribed an antibiotic, ask your doctor why it is necessary and what his basis for the prescription is. If the answer amounts to "just in case", you may want to seek a second opinion.

Randy McIntire is a technical writer specializing in mobility devices for seniors and the disabled. Randy's particular area of expertise is lift chairs. For more information about lift chairs, visit US Medical Supplies.